InvestorsHub Logo
Followers 30
Posts 2778
Boards Moderated 3
Alias Born 10/24/2015

Re: jondoeuk post# 167

Thursday, 09/30/2021 2:44:34 PM

Thursday, September 30, 2021 2:44:34 PM

Post# of 246
The ovarian patient with a confirmed CR had a high MAGE-A4 expression with 95% tumour cells with 3+ staining. Adding decitabine (hypomethylating agent and a potent inducer of TAAs) could selectively modulate TAA expression in TAA low-expressing tumour cells and enhance the therapy https://d201nm4szfwn7c.cloudfront.net/5f95dbd7-245e-4e65-9f36-1a99e28e5bba/7d9a26ec-fef3-42fb-b671-2a8889398f09/7d9a26ec-fef3-42fb-b671-2a8889398f09_viewable_rendition__v.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADAP News